Skip to main content

News Archive

News Archive - Erin Prater

Rebecsinib Clinical Trial Means New Options for Blood Cancer

A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.

Sanford Stem Cell Institute Brings Space Health Emphasis to Precision Medicine World Conference

Catriona Jamieson, MD, PhD, director of UC San Diego’s Sanford Stem Cell Institute chaired a daylong RNA, stem cell- and gene-based therapies track at the Precision Medicine World Conference bringing a unique space-health perspective to the conference with three other institute directors..

At Astrobiotech Event, Sanford Stem Cell Institute Celebrates 18 Launches of Space Research

This March, UC San Diego’s Sanford Stem Cell Institute celebrated its fourth annual Global Astrobiotechnology Hub seminar and 18 launches of scientific research — this as it prepares to send more experiments to space later this year.

From Rett and Pitt-Hopkins to ALS: 5 Rare Diseases UC San Diego Researchers are Tackling in the Lab

This Rare Disease Day (February 28, 2026), read on to learn more about five orphan conditions, the people they affect and the UC San Diego Sanford Stem Cell Institute researchers fanning the flames of hope for patients around the globe.

Can Stem Cells Seal Carol’s Fate With ‘The Others’? Expert Separates Pluribus’ Science Fact, Fiction

In the season finale of Apple TV's Pluribus, Carol learns that induced pluripotent stem cells from her frozen eggs could be used to unite her with The Others. Robert Signer, PhD, of the Sanford Stem Cell Institute’s Sanford Stem Cell Discovery Center, separates stem cell science fact from fiction.

Combination Therapy Could Expand Treatment Options for AML Patients, Extend Survival

Proteasome inhibitors have proven highly effective in multiple myeloma but not in acute myeloid leukemia. The addition of a drug that inactivates the HSF1 pathway or impairs autophagy could change that.

Small Nuclear RNA Base Editing a Safer Alternative to CRISPR, UC San Diego Researchers Find

Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale University researchers highlights an innovative approach that may be safer: small nuclear RNA editing.

CIRM Scholars Program Makes California a Rare ‘Powerhouse of Science’ in the United States

The California Institute for Regenerative Medicine (CIRM) Scholars program seeks to develop skilled leaders in the field of regenerative medicine who create safe, cutting-edge stem cell treatments for diseases without cure like cancer, diabetes, heart disease and HIV.

Search UC San Diego Today